PubMed Health⌕ Search

Biomedical subjects

P A Ouvry

Publications and source records attributed to P A Ouvry.

17 recordsLinked to original sources
PubMed1989

Telangiectasia and sclerotherapy.

The anatomy, physiology, and etiology of telangiectasia and related varicosities of the lower limbs are presented. Treatment by sclerotherapy is discussed, with various modalities investigated and compared.

Female↗
PubMedDate not supplied

[Vulvar varices].

Explore the source record for details and available documents.

Adult↗
PubMedDate not supplied

[Stripping using invagination over a calibrated stent].

After crossectomy which remains the most important stage, a short stripping is performed in an upward direction, substituting a packing for the olive shaped knob normally used. The width of this gauze packing depends on the diameter of the saphenous vein. Traction of the lower end of the stripper, at the ankle, pulls down the packing within the saphenous vein, causing its invagination. The saphenous vein is thus turned outside in over the packing as it comes out through the lower incision. Besides, this packing ensures haemostasis and is only removed at the end of the procedure. Advantages of this method: absence of haematomas and nerve lesions. Smaller lower incision.

Equipment Design↗
PubMedDate not supplied

[A trial of silver sulfadiazine in the local treatment of venous ulcer].

Silver sulfadiazine, in cream form, has been mostly used in the treatment of burns. Its trial in the treatment of leg ulcers has been satisfactory. This preparation is well tolerated, and effective on wound cleansing and granulation tissue formation. It is particularly indicated in cases of superinfected ulcers, effective on most Gram + and Gram - bacteria.

Administration, Cutaneous↗
PubMedDate not supplied

[Role of grafts in the treatment of resistant ulcers].

Despite a correction as complete as possible of the venous stasis, certain ulcers prove resistant to treatment. In these cases, grafts, whose active mechanism is still not well known in many respects, can turn out to be effective.

Chronic Disease↗
PubMedDate not supplied

[Familial case of Milroy-Meige-Nonne disease].

Milroy-Meige-Nonne's disease is an exceptional disorder. The authors give an account of a family in which 8 cases were enumerated spread over 4 generations. The clinical pictures given show lymphatic affection of varying severity. The authors take this opportunity to give short historical and anatomical reviews of the disease. Finally they describe current treatment.

Adult↗
PubMedDate not supplied

[A case of dysfibrinogenemia complicated by hemorrhage and thrombosis].

There are, as well as the more common coagulopathies such as deficiency in antithrombin III or Protein C, certain rare disorders complicated simultaneously by haemorrhage and thrombosis--such as dysfibrinogenemia--which can present very special therapeutic problems.

Afibrinogenemia↗
PubMedDate not supplied

[A new therapeutic approach in persistent postphlebitic ulcers].

Most post-phlebitic ulcers heal after a well-executed phlebological treatment on an ambulatory basis. The time it takes to heal is, on average, longer than that normal in the case of varicose ulcers. A certain number of post-phlebitic ulcers prove, however, to respond badly to the ambulatory treatment. In these cases the procedure described by the authors enables healing to take place by treating the venous stasis and the blood viscosity.

Adult↗
PubMedDate not supplied

The sclerotherapy of telangiectasia.

UNLABELLED: Indications. The sclerotherapy can be used in three sorts of telangiectasia: a) Telangiectasia associated with venous stasis. The practitioner must keep to one rule; sclerotherapy of varicose veins before sclerotherapy of telangiectasia. b) Single telangiectasia. c) Periodic telangiectasia. Technique. The material is: a) sclerosants: chromicized glycerin at 1,11% (Scleremo), polydacanol (Aetoxisclérol) at 0,50%; b) needles: 3/10, 4/10 or 5/10 mm in diameter; c) syringes, 3 ml; d) lenses magnifying X 2. Two important rules: a) progress from the largest to the smallest vessels; b) use little sclerosant at a time and many injections. Other recommendations: 3 or 4 weeks between consultations, compression. RESULTS: telangiectasia usually disappear in a few days. COMPLICATIONS: allergic reactions, cramps, scarring (excessive or extravascular injections), permanent pigmentation (excessive dosage). In conclusion, effectiveness of microsclerosis.

Humans↗
PubMedDate not supplied

[Lymphatic complications from variceal surgery].

INTRODUCTION: Lymphatic injuries are unavoidable during varicose vein surgery. However these injuries seldom lead to complications. This study was held to try to find an explanation to this contradiction which seems to be only noticeable. MATERIAL AND METHOD: If anatomy shows that it is impossible to operate on varicose veins without injuring lymphatic vessels, the regeneration power of these latters, known for a long time, is such that complications due to these injuries are all the more exceptional that surgeries are less traumatizing than it used to be. Nowadays, each surgeon is only faced to a small number of such complications during their career. This rareness makes a methodical personal study quasi-impossible. That is why we sent a questionnaire to about thirty surgeons specialized in this field. This questionnaire, about their experience, dealt with lymphatic complications they had met during varicose veins surgery. RESULTS: Twenty three answers were sent in time and deal with more than 184,000 surgeries. The lymphatic complication rate is about 8.7%, 5.4% of which are lymphorrhea, 2.6% of lymphocele, 1.09% of lymphangitis and 0.5% of lymphoedema. Of course, these figures are approximate. Lymphoedema is the only long-lasting lymphatic complication of the varicose veins surgery. CONCLUSIONS: According to us, sclerotherapy seems to be more effective than surgery, in case of signs, even benign, of lymphatic insufficiency.

Bandages↗